Skip to main content
SpringerLink
Log in

Levosulpiride

Levopraid®, RV 12309

  • Section 1: Antiemetics in Oncology
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Guslandi M. The clinical use of levosulpiride. Curr Ther Res 1993 May; 53: 484–501

    Article  Google Scholar 

  2. White JM, De Silva V, Sanchez I. Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia: frequency, activity and clinical significance. Saudi Med J 1990 May; 11: 208–13

    Google Scholar 

  3. Corazza GR, Biagi F, Albano O, et al. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol 1996 Jul–Aug; 28: 317–23

    PubMed  CAS  Google Scholar 

  4. Schiraldi GF, Lo Cicero S, Parodi GM, et al. Efficacy and safety of levosulpiride versus metoclopramide in patients with emesis induced by high doses of salmon calcitonin. Curr Ther Res 1993 Jan; 53: 42–7

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levosulpiride. Drugs R&D 2, 247–248 (1999). https://doi.org/10.2165/00126839-199902040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902040-00006

Keywords

Search

Navigation